The neural POU-domain proteins N-Oct 3 and N-Oct 5 were first identifi
ed in electrophoretic mobility retardation assays through their abilit
y to bind to the octamer sequence ATGCAAAT. These two N-Oct factors ar
e detected in extracts from tumor-derived and normal neural cells. The
y are present differentially, however, in extracts from melanocytes an
d melanoma cells: N-Oct 3 is present in extracts from both melanocytes
and melanoma cells, whereas N-Oct 5 is more evident in extracts from
metastatic melanoma cells. We show here that a cDNA encoding N-Oct 3 d
irects synthesis of both the N-Oct 3 and N-Oct 5 proteins and that the
N-Oct 5 protein in neural and melanoma-cell extracts is also related
to N-Oct 3. N-Oct 5, however, is apparently not expressed in vivo: It
is not detected if cells are rapidly lysed in SDS or if extracts are p
repared with a cocktail of protease inhibitors that includes the serin
e-protease inhibitor 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochl
oride (AEBSF). These data suggest that N-Oct 5 is a specific in vitro
proteolytic cleavage product of N-Oct 3 and is not directly related to
melanocyte malignancy.